Opinion

Published on 13 Jul 2022

LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer

in Cancer Immunity and Immunotherapy

Jialin Zhou
Chun Feng
Kai Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.911572

1,701 views

Review

Published on 08 Jul 2022

The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages

in Cancer Immunity and Immunotherapy

Yuying Tan
Lei Zhao
Yong-Guang Yang
Wentao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.953283

7,538 views
37 citations

Original Research

Published on 07 Jul 2022

Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)

in Cancer Immunity and Immunotherapy

Yuqin Song
Keshu Zhou
Chuan Jin
Zhengzi Qian
Ming Hou
Lei Fan
Fei Li
Kaiyang Ding
Hui Zhou
Xiaoling Li

Frontiers in Oncology

doi 10.3389/fonc.2022.925236

5,282 views
10 citations

Case Report

Published on 05 Jul 2022

Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review

in Cancer Immunity and Immunotherapy

Yuchen Wan
Zhixue Wang
Ning Yang
Fenye Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.911961

2,651 views
5 citations

Review

Published on 04 Jul 2022

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future

in Cancer Immunity and Immunotherapy

Zhengchao Zhang
Dong Li
Heng Yun
Wei Liu
Keqiang Chai
Jie Tong
Tongwei Zeng
Zhenghua Gao
Yongqiang Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.915171

6,465 views
7 citations

Original Research

Published on 04 Jul 2022

CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity

in Cancer Immunity and Immunotherapy

Pamina Contreras-Kallens
Felipe Gálvez-Jirón
Javiera De Solminihac
Ahmed Elhusseiny
Wilfredo A. González-Arriagada
Francisca Alcayaga-Miranda
Randolph J. Noelle
Karina Pino-Lagos

Frontiers in Oncology

doi 10.3389/fonc.2022.928498

3,115 views

Original Research

Published on 30 Jun 2022

Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells

in Cancer Immunity and Immunotherapy

Michele Tomasi
Elena Caproni
Mattia Benedet
Ilaria Zanella
Sebastiano Giorgetta
Mattia Dalsass
Enrico König
Assunta Gagliardi
Laura Fantappiè
Alvise Berti

Frontiers in Oncology

doi 10.3389/fonc.2022.912639

4,705 views
12 citations

Review

Published on 29 Jun 2022

Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx® Digital Spatial Profiler

in Cancer Immunity and Immunotherapy

Sharia Hernandez
Rossana Lazcano
Alejandra Serrano
Steven Powell
Larissa Kostousov
Jay Mehta
Khaja Khan
Wei Lu
Luisa M. Solis

Frontiers in Oncology

doi 10.3389/fonc.2022.890410

24,612 views
52 citations

Review

Published on 28 Jun 2022

Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches

in Cancer Immunity and Immunotherapy

Carlotta Ceccon
Valentina Angerilli
Cosimo Rasola
Letizia Procaccio
Marianna Sabbadin
Francesca Bergamo
Umberto Malapelle
Sara Lonardi
Matteo Fassan

Frontiers in Oncology

doi 10.3389/fonc.2022.930108

3,663 views
7 citations

Original Research

Published on 28 Jun 2022

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity

in Cancer Immunity and Immunotherapy

Bin Zhang
Yongheng Shu
Shichuan Hu
Zhongbing Qi
Yanwei Chen
Jinhu Ma
Yunmeng Wang
Ping Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.897561

3,349 views
5 citations

Review

Published on 27 Jun 2022

Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research

in Cancer Immunity and Immunotherapy

Frank Rojas
Sharia Hernandez
Rossana Lazcano
Caddie Laberiano-Fernandez
Edwin Roger Parra

Frontiers in Oncology

doi 10.3389/fonc.2022.889886

10,265 views
20 citations

Original Research

Published on 27 Jun 2022

Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment

in Cancer Immunity and Immunotherapy

Kevin Atsou
Sokchea Khou
Fabienne Anjuère
Véronique M. Braud
Thierry Goudon

Frontiers in Oncology

doi 10.3389/fonc.2022.878827

2,899 views
4 citations

Original Research

Published on 24 Jun 2022

Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma

in Cancer Immunity and Immunotherapy

Wei Peng
Jin Chen
Yanping Xiao
Guangjian Su
Yan Chen
Zhaolei Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.912624

2,603 views
2 citations

Systematic Review

Published on 23 Jun 2022

Risk of Adverse Events in Cancer Patients Receiving Nivolumab With Ipilimumab: A Meta-Analysis

in Cancer Immunity and Immunotherapy

Xin Zhao
Fengwei Gao
Jie Yang
Hua Fan
Qingyun Xie
Kangyi Jiang
Jie Gong
Benjian Gao
Qian Yang
Zehua Lei

Frontiers in Oncology

doi 10.3389/fonc.2022.877434

2,870 views
10 citations

Case Report

Published on 23 Jun 2022

Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis

in Cancer Immunity and Immunotherapy

Leilei Fang
Changqin Liu
Xiaomin Sun
Zhanju Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.925964

1,893 views
1 citation

Review

Published on 23 Jun 2022

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy

in Cancer Immunity and Immunotherapy

Wiktoria Strasenburg
Jakub Jóźwicki
Justyna Durślewicz
Błażej Kuffel
Martyna Parol Kulczyk
Adam Kowalewski
Dariusz Grzanka
Tomasz Drewa
Jan Adamowicz

Frontiers in Oncology

doi 10.3389/fonc.2022.909767

6,742 views
26 citations

Navigation group

Articles

LCOR Reverses Immune-Checkpoint Inhibitors Therapy Resistance Out of IFN Constraint in Triple-Negative Breast Cancer

The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages

Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)

Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future

CD49b Targeting Inhibits Tumor Growth and Boosts Anti-tumor Immunity

Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells

Challenges and Opportunities for Immunoprofiling Using a Spatial High-Plex Technology: The NanoString GeoMx® Digital Spatial Profiler

Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity

Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research

Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment

Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma

Risk of Adverse Events in Cancer Patients Receiving Nivolumab With Ipilimumab: A Meta-Analysis

Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy